- Scientists predicted that British breast cancer cases could rise by up to 60 percent in the next two decades.
- The RCOG disputed the study's findings as it has all other abortion breast cancer links.
- Reproductive, hormonal and pregnancy related risk factors are particularly relevant to breast cancer incidence.
- Abortions before a full term pregnancy are more common among higher social classes of women.
- Unlike other cancers, there is a higher incidence of breast cancer and mortality among the higher social classes.
An independent study commissioned by a British anti-abortion group has found that
a surge in breast cancer rates in the U.K. and several European countries is
most likely attributable to a rise in abortion.
Scientists with the Pension and Population Research Institute (PAPRI) said that if current trends continue, British breast cancer cases could rise by up to 60 percent in the next two decades.
The PAPRI report found that the number of breast cancer cases in England and Wales could rise from about 35,000 in 1997 to 77,000 in 2023.
Patrick Carroll, author of the study, said that the consequences of abortion on the health of a woman are starting to appear in the general population.
In addition to tracking abortion and cancer rates in the U.K., the study examined similar statistics in Finland, Sweden and the Czech Republic. Carroll said that the correlation between abortion and breast cancer was about the same in each country.
But the Royal College of Obstetricians and Gynaecologists (RCOG), which has consistently denied any real link between abortion and breast cancer rates, disputed the institute's findings.
Dr Carroll remarks of the British situation, "Unless there is a major improvement in treatment, including a reduction in the waiting-lists, the number of women who die from the disease will rise alarmingly."
Figure 1 illustrates a recent ONS report and shows how the highest social class has a PMR(Proportional Mortality Ratio) of 174 for the years 1997-2000 compared to a PMR of 169 for the years 1993-96.
By considering known risk factors that might explain this increase, there is the potential to model and forecast any further increase in the gradient to be anticipated in the years 2001-2004 when ONS next repeat the exercise.
Reproductive, hormonal and pregnancy related risk factors are especially relevant to breast cancer incidence.
Figure 2 shows the high correlation, with coefficient over 0.9, between cumulated cohort abortion rates and cumulated cohort breast cancer rates for new malignant cancers reported for women within ages 50-54.
This is higher than the negative correlation with fertility, or number of live-born children, of around 0.3. Fertility is also a useful predictor of British trends. However age at first birth and childlessness, that are also well established as risk factors for breast cancer, do not explain the observed increase in breast cancer incidence in Great Britain.
Consideration of Trends in Nulliparous Abortions explains the increased reverse gradient in British Breast Cancer and can be used to predict further increases in this gradient.
Nulliparous abortions, when the woman has an abortion before she has any full term pregnancy, are especially common in the higher social classes of women. Graduate and professional women tend to have children at a later age. When they become pregnant as teenagers or in their twenties, they are more likely to choose an abortion than lower class women.
Unlike other cancers, where the lower social classes have the higher incidence and the higher mortality, female breast cancer has a reverse gradient.
Figure 3 shows how there is a steep increase in the cumulated cohort rate of nulliparous abortions for successive birth cohorts of English women. This is steeper than the cumulated cohort rate for all abortions that runs parallel in Figure 2 to the increase in breast cancer.
A simple additive probability model has been developed to predict the further increases to be expected in post-menopausal Breast Cancer Incidence in future years using accumulated cohort Fertility and Abortion rates as explanatory variables.
This modelling can also be adapted to forecast a further increase in the reverse gradient across social class of English Breast Cancer, when the additionally carcinogenic effects of nulliparous abortions are explicitly estimated.
An abortion doctor in Australia settled with a breast cancer victim. The woman had sued the abortionist for not telling her about research findings linking abortion to breast cancer. Although a confidentiality agreement prevents details of the settlement from being released, Australian attorney Charles Francis,Q.C. is confident that other cases can be brought against abortionists on the same grounds. "It seemed to me that the evidence [of an abortion breast cancer link] was fairly strong," Francis remarked, "Certainly strong enough for a good chance of winning."
In another case in New South Wales, a former patient sued a hospital and an abortionist for failing to warn her that she might subsequently have a bad psychiatric reaction, and for failure to warn of the increased breast-cancer risk.
Around one quarter of women who get breast cancer, die. At a press conference to launch the PAPRI report, it was pointed out that giving birth within five years of having an abortion can reduce the risk of breast cancer. Breast-feeding the baby has the potential to lessen the risk further.
A Death Sentence in Developing Countries
In the developing world, those women diagnosed with breast cancer are unlikely to get treatment. And with the relatively unsophisticated treatments developing countries have available,those few who receive treatment available are unlikely to survive.
In the developing world, breast cancer is almost always a death sentence.
Patrick Carroll, "Abortion and Other Pregnancy-Related Risk Factors in Female Breast Cancer," Pension and Population Research Institute (PAPRI), 4 December 2001. Copies are available from:
PAPRI Pension and Population Research Institute
35 Canonbury Road,
London, N1 2DG, UK.
tel 020 7354 5667
fax 020 7226 6601
Read also Abortion and Breast Cancer -The Estrogen Connection